NCT06083909

Sarcopenic Obesity in the Elderly

Sarcopenic Obesity as Risk Factor for Insulin Resistance in the Elderly

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 97 (actual)
• Sponsor: University of Central Florida · Academic / Other
• Sex: All
• Age: 65 Years – 85 Years
• Healthy volunteers: Accepted

Summary

Ageing is associated with progressive and generalized loss of muscle mass and muscle function, also known as Sarcopenia. Increasingly, obesity has become a compounding factor in ageing-related sarcopenia. The coexistence of obesity and sarcopenia is termed sarcopenic obesity (SO). Older adults with SO are at higher risks of developing diabetes, hypertension, stroke, cardiovascular diseases, and cognitive dysfunction than those older adults who suffer from sarcopenia alone or obesity alone. However, there is insufficient information with regard to the interplay between obesity and sarcopenia. The primary objective of this study is to investigate the impact of SO on insulin resistance in people aged 65-85. Our hypothesis is that SO positively influences insulin resistance in the elderly. We propose to investigate sarcopenia and obesity as risk factors for insulin resistance in the geriatric (65-85 years old) population.

Conditions

• Sarcopenic Obesity
• Diabetes

Timeline

• Start date: 2022-04-06
• Primary completion: 2023-04-19
• Completion: 2023-05-08
• First posted: 2023-10-16
• Last updated: 2023-10-19

Locations

1 site across 1 country: United States